Keywords: درمان های هدفمند; Personalized medicine; Cancer genomics; Targeted therapies; Genomic testing; Ethics; Social implications
مقالات ISI درمان های هدفمند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان های هدفمند; Late recurrence; Targeted therapies; Treatment response; Survival outcome; Renal cell carcinoma;
Keywords: درمان های هدفمند; Personalised medicine; Metastatic cancer; Targeted therapies;
Keywords: درمان های هدفمند; Personalized medicine; Targeted therapies; Hematology; Drug Delivery
Keywords: درمان های هدفمند; Conversion therapy; Colorectal cancer; Colorectal cancer metastases; Metastasectomy; Targeted therapies; Chemotherapy; Resection
Keywords: درمان های هدفمند; Adrenocortical carcinoma; Therapeutics; Targeted therapies; Metastatic disease
Keywords: درمان های هدفمند; Targeted therapies; Metastatic esophageal cancer;
Keywords: درمان های هدفمند; Bile duct cancer cholangiocarcinoma; Hepatocellular carcinoma; Systemic therapy; Chemotherapy; Targeted therapies;
Keywords: درمان های هدفمند; Cancer cell biology; Cell signaling; Tumorigenesis; Targeted therapies;
Keywords: درمان های هدفمند; Breast cancer; Microenvironment; Signaling pathways; Targeted therapies; Chemo-resistance;
Keywords: درمان های هدفمند; Head & neck cancer; Squamous cell carcinoma; Targeted therapies; Treatment; Molecular biology;
Keywords: درمان های هدفمند; Palliation; Cholangiocarcinoma; Hepatocellular carcinoma; Systemic therapies; Targeted therapies; Chemoembolization; Endoscopic therapies;
Keywords: درمان های هدفمند; Targeted therapies; Therapeutic drug monitoring; Pharmacokinetics; Variability; Tyrosine kinase inhibitors; Protein kinase inhibitors; Monoclonal antibodies; Target concentration
Keywords: درمان های هدفمند; Hodgkin lymphoma; Relapsed disease; Targeted therapies; Brentuximab vedotin;
Keywords: درمان های هدفمند; Melanoma; Prognosis; Biology; Immunotherapy; Targeted therapies; Neoadjuvant; Adjuvant; Combination therapy;
Keywords: درمان های هدفمند; 5FU; 5-fluorouracile; ABC; ATP-binding cassette; AUC; area under the curve; BCRP; breast cancer resistance protein; Cmax; maximum (peak) plasma concentration; CYP; cytochrome p450 enzymes; DDI; drug-drug interactions; EIAEDS; enzyme-inducing antiepilept
Keywords: درمان های هدفمند; Cancer; Resistance; Anti-cancer agents; Targeted therapies; Hypoxia; Cancer stem cells;
Keywords: درمان های هدفمند; Anti-angiogenesis; Resistance; Targeted therapies; Predictive markers; Autophagy; AKT/PKB; protein kinaseB; BMDCs; bone marrow-derived cells; BVZ; bevacizumab/Avastin; CSC; cancer stem-like cells; EGF; epidermal growth factor; EPC; endothelial progenitor
Keywords: درمان های هدفمند; Breast cancer; Cancer metastasis; Chemoresistance; Drug resistance; EMT; Pancreatic cancer; Targeted therapies
Keywords: درمان های هدفمند; Translational research; Oncology; Breast cancer; Molecular diagnosis; Targeted therapies; Genomics
L'immunohistochimie (clone VE1) est une méthode économique, spécifique et sensible pour détecter la présence d'une mutation BRAFV600E dans le mélanome
Keywords: درمان های هدفمند; BRAF p.Val600Glu (V600E); Immunohistochimie; Mélanome métastatique; Thérapies ciblées; BRAF pVal600Glu (V600E); Immunohistochemistry; Metastatic melanoma; Targeted therapies;
HER2-positive breast cancer: Current and new therapeutic strategies
Keywords: درمان های هدفمند; HER2 positive; Targeted therapies; Drugs in development; Advanced breast cancer;
What is the optimal management of older CLL patients?
Keywords: درمان های هدفمند; Chronic lymphocytic leukemia; Elderly; Geriatric assessment; Targeted therapies;
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Keywords: درمان های هدفمند; Liquid biopsy; NSCLC; cfDNA; ctDNA; Biomarkers; Resistance; Molecular analysis; Targeted therapies;
PAX3-FOXO1: Zooming in on an “undruggable” target
Keywords: درمان های هدفمند; Targeted therapies; Fusion transcription factors; PAX3-FOXO1; Alveolar rhabdomyosarcoma; Post-translational modifications; Protein turnover;
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction)
Keywords: درمان های هدفمند; Biological therapies; Infection; Monoclonal antibodies; Recommendations; Review; Small-molecule inhibitors; Targeted therapies;
Colony-stimulating factor-1 receptor provides a growth advantage in epithelial cancer cell line A431 in the presence of epidermal growth factor receptor inhibitor gefitinib
Keywords: درمان های هدفمند; CSF-1R; Epithelial expression; Carcinoma; Targeted therapies; Gefitinib sensitivity;
Aptamers as potential therapeutic agents for ovarian cancer
Keywords: درمان های هدفمند; Aptamers; Antibodies; EpCAM; Therapeutic; Targeted therapies; Ovarian cancer; ADCC; antibody-dependent cell-mediated cytotoxicity; ABC; ATP-binding cassette; BBB; blood brain barrier; CDC; complement-mediated cytolysis; CA125; Cancer Antigen 125; CSCs; ca
Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology
Keywords: درمان های هدفمند; Chemotherapy; Combination strategies; Immunotherapy; Second-line treatment; Targeted therapies;
EJC Biennial ReportEuropean Journal of Cancer's Biennial report on soft tissue and visceral sarcomas or the rapid evolution of treatment concepts in sarcomas
Keywords: درمان های هدفمند; Sarcoma; Surgery; Network; Expert centres; Targeted therapies; Adjuvant; Neoadjuvant; Molecular classification;
Stratégie de prise en charge de la polyarthrite rhumatoïde : traitement précoce et traitement ciblé
Keywords: درمان های هدفمند; Polyarthrite rhumatoïde; Stratégies thérapeutiques; Biothérapies; Traitements de fond; Biomarqueurs; Rheumatoid arthritis; Therapeutic strategies; Biological treatments; Biomarkers; Targeted therapies;
Perspectives in pathologyMultisite tumor sampling: a new tumor selection method to enhance intratumor heterogeneity detection
Keywords: درمان های هدفمند; Tumor sampling; Intratumor heterogeneity; Targeted therapies; Carcinogenesis; Pathology; Laboratory cost;
Original ResearchClinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit
Keywords: درمان های هدفمند; Mesothelioma; Phase 1; Drug development; PI3K; Targeted therapies;
Quelle est la meilleure séquence thérapeutique pour les CBNPC non-opérables ?
Keywords: درمان های هدفمند; Cancer bronchique non à petites cellules; Stade III; Radiothérapie; Chimiothérapie; Thérapeutiques ciblées; Non-small cell lung cancer; Stage III; Chemotherapy; Radiotherapy; Targeted therapies;
MET Exon 14 Alterations and New Resistance Mutations to Tyrosine Kinase Inhibitors: Risk of Inadequate Detection with Current Amplicon-Based NGS Panels
Keywords: درمان های هدفمند; Non-small cell lung cancer; Molecular testing; Targeted therapies; NGS cancer panels;
Traitements péri-opératoires des carcinomes bronchiques non à petites cellules
Keywords: درمان های هدفمند; Cancer bronchique non à petites cellules; Chirurgie; Chimiothérapie; Radiothérapie; Traitements ciblés; Non-small cell lung cancer; Surgery; Chemotherapy; Radiotherapy; Targeted therapies;
Pharmacologic Costs of Tyrosine Kinase Inhibitors in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations: A Review of Pivotal Phase III Randomized Controlled Trials
Keywords: درمان های هدفمند; Advanced NSCLC; Costs of drugs; First-line chemotherapy; Randomized phase III trials; Targeted therapies;
Médicaments du cancer : quelles innovations et à quel prix ?
Keywords: درمان های هدفمند; Innovations thérapeutiques; Thérapies ciblées; Médecine de précision; Immunothérapie; Prix des médicaments; Toxicité financière; Therapeutic innovations; Targeted therapies; Precision medicine; Immunotherapy; Drug price; Financial toxicity;
CHK1 and replicative stress in T-cell leukemia: Can an irreverent tumor suppressor end up playing the oncogene?
Keywords: درمان های هدفمند; CHK1; Replicative stress; ATR; ATM; T-ALL; T-cell acute lymphoblastic leukemia; Targeted therapies;
Thirty years of phase I radiochemotherapy trials: Latest development
Keywords: درمان های هدفمند; Concomitant radiochemotherapy; Dose escalation; Maximum tolerated dose; Clinical trials, phase I as topic; Research design; Review; Targeted therapies;
Les populations particulières : les personnes âgées atteintes d'un cancer bronchique
Keywords: درمان های هدفمند; Cancer bronchique; Personnes âgées; Ãvaluation gériatrique; Chirurgie; Radiothérapie; Chimiothérapie; Thérapies ciblées; Lung cancer; Elderly; Geriatric assessment; Surgery; Radiotherapy; Chemotherapy; Targeted therapies;
The Pharmacological Costs of First-Line Therapies in Unselected Patients With Advanced Colorectal Cancer: A Review of Published Phase III Trials
Keywords: درمان های هدفمند; Advanced colorectal cancer; Costs of drugs; First-line therapy; Randomized phase III trials; Targeted therapies;
Étude des facteurs pronostiques pour le carcinome rénal métastatique traité par une deuxième ligne de thérapies ciblées
Keywords: درمان های هدفمند; Facteurs pronostiques; Cancer du rein métastatique; Thérapies ciblées; Survie; Toxicité induitePrognostic factors; Metastatic renal cell carcinoma; Targeted therapies; Survival; Induced toxicity
Revue généraleRadiothérapie et thérapies ciblées/immunothérapieRadiotherapy and targeted therapy/immunotherapy
Keywords: درمان های هدفمند; Thérapies ciblées; Immunothérapie; Radiothérapie; Radiothérapie stéréotaxique; Targeted therapies; Immunotherapy; Radiation therapy; Stereotactic radiotherapy;
Les infirmières cliniciennes améliorent la gestion des toxicités des patients traités par sorafénib pour carcinome hépatocellulaire
Keywords: درمان های هدفمند; Infirmières; Ãducation thérapeutique; Thérapies ciblées; Toxicité; Qualité de vie; Quality of life; Clinical nurse specialist; Targeted therapies; Educational program; Toxicity;
Les cancers bronchiques non à petites cellules EGFR-mutés
Keywords: درمان های هدفمند; Mutations EGFR; Traitements ciblés; EGFR mutation; Targeted therapies; Resistance mutations; T790M;
Optimizing clinical benefit with targeted treatment in mRCC: “Tumor growth rate” as an alternative clinical endpoint
Keywords: درمان های هدفمند; Everolimus; mRCC; Tumor response; RECIST; Targeted therapies
Irreversible inhibition of Î16HER2 is necessary to suppress Î16HER2-positive breast carcinomas resistant to Lapatinib
Keywords: درمان های هدفمند; HER2 isoform; Breast cancer; Î16HER2 mice; Targeted therapies; Drug resistances;
Place du ruxolitinib dans la stratégie thérapeutique des syndromes myéloprolifératifs
Keywords: درمان های هدفمند; Ruxolitinib; Syndromes; myéloprolifératifs; Polyglobulie de Vaquez; Myélofibrose; Thérapies ciblées; Inhibiteurs de JAK2; Ruxolitinib; Myeloproliferative; neoplasms; Polycythemia vera; Myelofibrosis; Targeted therapies; JAK2 inhibitors;
ESMO ECCO 2015Â : les temps forts de l'immunothérapie et des thérapies ciblées
Keywords: درمان های هدفمند; Immunothérapies; Thérapies ciblées; Médecine personnalisée; Essai de phases précoces; Immunotherapies; Targeted therapies; Personalized medicine; Early phase studies;